Mongolia vs Tunisia: Access to anti-retroviral drugs, female
Mongolia
36.0%
in 2024
Tunisia
33.0%
in 2024
Mongolia rank
130th
Tunisia rank
133rd
Access to anti-retroviral drugs, female over time
- Mongolia
- Tunisia
How they compare
Mongolia currently reports 36.0% against 33.0% in Tunisia, a difference of 3.0%.
That makes Mongolia's figure about 1.1 times Tunisia's.
The two have swapped places 5 times across 25 shared years of data; in 2000 it was Tunisia ahead.
Mongolia ranks 130th and Tunisia ranks 133rd of 141 countries.
Across the 3 decades both report, Mongolia averaged higher in 2 and Tunisia in 1.
Head to head by decade
| Decade | Mongolia | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.2% | 4.4% | 3.2% | Tunisia |
| 2010s | 24.1% | 19.9% | 4.2% | Mongolia |
| 2020s | 38.8% | 33.8% | 5.0% | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Mongolia or Tunisia?
- Mongolia, at 36.0% against 33.0% in Tunisia as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Mongolia and Tunisia?
- 3.0%, with Mongolia ahead.
- How many years of comparable data are there for Mongolia and Tunisia?
- 25 years are reported by both, from 2000 to 2024.
- How do Mongolia and Tunisia rank globally for access to anti-retroviral drugs, female?
- Mongolia ranks 130th and Tunisia ranks 133rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.